Core Challenges of Outdated SCEs, and How to Overcome Them
Instem Team
In this blog, we discuss the hidden cost of PC-SAS, fragmentation, and manual validation.
Clinical Blog
Application Areas
Clinical Stage
Product
Beyond the PPD Label: Clearer Language for Stronger Clinical Trial Transparency Submissions
Instem Team
In this blog, we discuss PPD, what different agencies actually care about, and how to navigate CTT language in an ever-changing regulatory landscape.
Introducing Blur™ 2.10: Faster, More Precise Clinical Trial De-Identification
Instem Team
With the release of Blur™ 2.10, Instem is introducing a broad set of enhancements across CSR anonymization, data de-identification, risk simulation, administration, performance, and security.
The Changing Language of Clinical Trial Transparency
Instem Team
This blog examines how clinical trial transparency regulations are evolving and what organizations can do to keep up with expectations.
d-wise Appoints 2x-CEO, ex-Labcorp Head of Software Solutions to Drive Next Phase of Strategy & Growth
BOSTON, USA – 21 April 2026: d-wise (an Instem company), a leader in statistical computing infrastructure and clinical trial transparency, today announced the appointment of Christine Oliver as its President. Christine brings over two decades...
Challenges and Best Practices of Open-Source Solutions for Clinical Use
Instem Team
Read this blog to learn about the challenges and best practices when using open-source solutions in clinical trial data analytics.
Stay up to Date
Get expert tips, industry news, and fresh content delivered to your inbox.
